Delivery Order SPE2DB22D2007-SPE2DB25FJ4PE
- Not listed
- The Defense Logistics Agency awarded a $6,007.90 delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count) on April 24, 2025, with an ultimate completion date of May 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tasigna 150 mg capsules (28-count units) with a ceiling value of $6,007.90. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 29, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency has awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for the supply of Tasigna 200 mg capsules (28-count packaging). This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract. This non-competitive delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, will be performed at the awardee's facility in Conshohocken, Pennsylvania. Tasigna is a specialized oncology medication used in the treatment of certain types of leukemia, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count packaging) with a firm fixed price structure. This non-set-aside contract was awarded on July 30, 2025, with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract with a ceiling value of $6,007.90 and an ultimate completion date of September 24, 2025. This is a non-set-aside, competitively awarded delivery order issued as a child contract against AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (quantity: 28) under a firm fixed price contract. This delivery order is not set-aside and was competitively awarded. The contract is scheduled for completion by August 18, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tasigna is a prescription medication used in the treatment of...
- The Defense Logistics Agency awarded a $6,007.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tasigna 200 mg capsules (28-count units) on September 15, 2025, with an ultimate completion date of October 6, 2025. The contract is unclassified with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a critical vendor in the federal medical procurement supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count) valued at $6,007.90 under a firm fixed-price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be supplied to the place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tasigna 150 mg capsules (28-count units) with a ceiling value of $6,007.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement under the company's existing...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4PEDelivery Order
The Defense Logistics Agency awarded a $6,007.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order is to be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. Tasigna is a specialty pharmaceutical used in the treatment of chronic myeloid leukemia, reflecting the breadth of oncology and specialized medications supplied through AmerisourceBergen's federal pharmaceutical support vehicle. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its comprehensive prime vendor contract covering brand-name and generic medications, vaccines, and specialized medical supplies. The award demonstrates the company's competitive capability to fulfill federal medical procurement requirements across multiple therapeutic domains supporting defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/3/25 |